Costs of bleeding on long-term antiplatelet treatment without routine co-prescription of proton-pump inhibitors

Background: Long-term antiplatelet treatment is associated with major bleeding. Aims: To determine the costs associated with major bleeding in patients treated with aspirin-base...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Luengo-Fernandez, R, Li, L, Rothwell, PM
Format:	Journal article
Język:	English
Wydane:	SAGE Publications 2019

Podobne zapisy

Proton Pump Inhibitors Use in Patients With Ischemic Stroke on Dual Antiplatelet Therapy at Low Risk of Upper Gastrointestinal Bleeding
od: Minyoul Baik, i wsp.
Wydane: (2025-01-01)

Proton Pump Inhibitor for Gastrointestinal Bleeding in Patients with Myocardial Infarction on Dual-Antiplatelet Therapy: A Nationwide Cohort Study
od: Minyoul Baik, i wsp.
Wydane: (2024-06-01)

Antiplatelet agents and proton pump inhibitors &ndash; personalizing treatment
od: Eugene Lin, i wsp.
Wydane: (2010-06-01)

Antiplatelet drugs and gastrointestinal disorders: when and how effective are inhibitors of proton pump?
od: Oksana Mikhaylovna Drapkina, i wsp.
Wydane: (2011-10-01)

Prescription Pattern of Proton Pump Inhibitors at Hospital Admission and Discharge
od: Verónica Gamelas, i wsp.
Wydane: (2018-05-01)

The influence of changes in hospital drug formulary on the prescription of proton pump inhibitors
od: Raquel Vázquez-Mourelle, i wsp.
Wydane: (2017-01-01)

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding
od: G Leontiadis, i wsp.
Wydane: (2007-12-01)

Antisecretory treatment efficacy by proton pump inhibitors at gastroduodenal ulcer bleedings
od: M. A. Evseyev, i wsp.
Wydane: (2010-06-01)

Are higher doses of proton pump inhibitors better in acute peptic bleeding?
od: Alejandro Villalón, i wsp.
Wydane: (2016-06-01)

BEHIND THE PROTON PUMP INHIBITOR PRESCRIPTION: AN INTERNATIONAL SURVEY ON PHYSICIAN PRACTICES AND KNOWLEDGE
od: Jean Félix PIÑERÚA-GONSÁLVEZ, i wsp.
Wydane: (2024-03-01)

Proton pump inhibitors overuse: only inappropriate prescriptions or further iatrogenic damage?
od: Mario Visconti
Wydane: (2015-09-01)

Prescriptive Appropriateness: Inhospital Adherence to Proton Pump Inhibitors Deprescription Flow Chart
od: Giammarco Baiardi, i wsp.
Wydane: (2023-04-01)

Improving use of proton pump inhibitors with dual antiplatelet therapy in patients admitted with acute coronary syndrome
od: Ashwin Radhakrishnan, i wsp.
Wydane: (2022-10-01)

The relationship between the combined use of various proton pump inhibitors with antiplatelet drugs and the risk of cardiovascular complications
od: O D Ostroumova, i wsp.
Wydane: (2019-08-01)

Refining prediction of major bleeding on antiplatelet treatment after transient ischaemic attack or ischaemic stroke
od: Hilkens, NA, i wsp.
Wydane: (2020)

The risk of upper gastrointestinal bleeding associated with concomitant proton pump inhibitor administration during dual antiplatelet therapy with aspirin and prasugrel: a retrospective single-center study
od: Yutaro Ide, i wsp.
Wydane: (2024-11-01)

High or Nonhigh Doses of Proton Pump Inhibitors for Patients with Peptic Ulcer Bleeding?
od: Yu-Hsi Hsieh, i wsp.
Wydane: (2013-01-01)

Appropriateness of proton pump inhibitors prescription in patients admitted to a Malaysian tertiary hospital
od: Then, Ru Fah, i wsp.
Wydane: (2019)

Determinants of and interventions for Proton Pump Inhibitor prescription behavior: A systematic scoping review
od: L. C. van Gestel, i wsp.
Wydane: (2024-06-01)

Prevention of gastrointestinal bleeding in patients receiving oral anticoagulants: focus on proton pump inhibitors
od: O. D. Ostroumova, i wsp.
Wydane: (2019-11-01)

The consequences of long-term therapy with proton pump inhibitors
od: Zuzanna Drygała, i wsp.
Wydane: (2024-01-01)

Proton-pump inhibitors
od: Vasudevan G. Naidoo
Wydane: (2015-05-01)

Intermittent Proton Pump Inhibitor Therapy in Low-Risk Non-Variceal Upper Gastrointestinal Bleeding May Be Significantly Cost-Saving
od: Yang Lei, i wsp.
Wydane: (2023-07-01)

Significance of serological atrophic gastritis on proton pump inhibitor prescriptions and referrals to gastroscopy in the general population
od: Tor Persson, i wsp.
Wydane: (2024-09-01)

Non-prescription proton-pump inhibitors for self-treating frequent heartburn: the role of the Canadian pharmacist
od: Armstrong D, i wsp.
Wydane: (2016-12-01)

Risk of upper gastrointestinal bleeding in patients on oral anticoagulant and proton pump inhibitor co-therapy.
od: Hyun-Jung Lee, i wsp.
Wydane: (2021-01-01)

Appropriateness of Antiplatelet Therapy and Proton Pump Inhibitor Prescribing in End-Stage Kidney Disease: A Retrospective Quality Investigation Study
od: Michael Che, i wsp.
Wydane: (2025-01-01)

Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors
od: Simone Janett, i wsp.
Wydane: (2015-01-01)

Association of Long-term Use of Proton Pump Inhibitors with Mortality
od: Da Hyun Jung
Wydane: (2022-10-01)

Low adherence to national guidelines for proton-pump inhibitor prescription in patients receiving combination aspirin and anticoagulation
od: Rajani Sharma, i wsp.
Wydane: (2017-05-01)

Lifestyle‐ and comorbidity‐related factors for the prescription of proton pump inhibitors after Helicobacter pylori eradication in Japan
od: Furitsu Shimada, i wsp.
Wydane: (2021-11-01)

Deprescribing proton pump inhibitors
od: Kim Jun Kevin Teh, i wsp.
Wydane: (2023-08-01)

Safety of proton pump inhibitors
od: Ye. A. Losik
Wydane: (2016-08-01)

Pharmacogenetics of proton pump inhibitors
od: M. V. Leonova
Wydane: (2015-12-01)

Cost-Effectiveness of Intravenous Proton Pump Inhibitors in High-Risk Bleeders
od: Sander Veldhuyzen van Zanten
Wydane: (2004-01-01)

The costly case of proton-pump inhibitors: a single-center experience
od: Vishnu Charan Suresh Kumar, i wsp.
Wydane: (2020-05-01)

Proton pump inhibitors: potential cost reductions by applying prescribing guidelines
od: Cahir Caitriona, i wsp.
Wydane: (2012-11-01)

Nonvitamin K oral anticoagulants with proton pump inhibitor cotherapy ameliorated the risk of upper gastrointestinal bleeding
od: Parata Chaiyana, i wsp.
Wydane: (2023-10-01)

Hypoalbuminemia is a predictor of mortality and rebleeding in peptic ulcer bleeding under proton pump inhibitor use
od: Hsiu-Chi Cheng, i wsp.
Wydane: (2018-04-01)

Comorbid patient with GERD and cardiovascular disease receiving antiplatelet therapy. The possibilities of choosing a proton pump inhibitor on a case study
od: I. G. Pakhomova
Wydane: (2019-10-01)